Tag: cancer research
AI minibinders bind PD-L1 but falter on other cancer targets
New screens show AI-designed minibinders hit PD-L1 but struggle on other cancer targets.
Tempus PRISM2 pathology model answers diagnostics from plain prompts
Tempus's PRISM2 foundation model matches or beats rivals on diagnostic and prognostic pathology tasks.